The mechanism of action of very 
INTRODUCTION
During the last decade a considerable amount of information has been obtained concerning the promi¬ nent role of receptors in the mechanism of action of steroid hormones. Extensive investigations have been carried out using rodent and human lymphoid cells to measure the number of glucocorticoid receptors and to determine the physiological actions of these steroids in vitro (Munck & Leung, 1977;  Lippman, 1979; Young, Nicholson, Guyette et al. 1979 ; Homo, Picard, Durant et al. 1980 ; Homo-Delarche, 1984) .
These experiments, however, failed to explain fully the differences in the steroid sensitivities between corticosensitive species or, in a given species, among the different lymphoid organs or lymphoid cell types. For example, administration of cortisol to rodents led to the almost complete disappearance of the thymus gland, whereas the effect on spleen and lymph nodes was much less marked (Ishidate & Metcalf, 1963; Cohen & Claman, 1971; Weissman, 1973; Duval, Dardenne, Dausse & Homo, 1977) . Moreover, the variability of the clinical response to glucocorticoids may also be related to individual and species differ¬ ences in the bioavailability of the administered drugs. This parameter depends upon numerous factors, including the intrinsic potency of the molecule, the absorption and distribution of the steroid and its metabolic degradation (Stubbs, 1975; Ballard, 1979; Morris, 1980 (Fan, Yu, Clements et al. 1978; Baylis, Williams, English et al. 1982; Weiss, 1982) . On the other hand, high doses of cortisol (10-20 mg/animal, i.e. 500-1000 mg/kg) have routinely been used to isolate a small population of corticoresistant medullary thymocytes from the rodent thymus (Blomgren & Anderson, 1969; (Miyata & Takaya, 1983) , and macrophages rapidly infiltrate the thymus following glucocorticoid admin¬ istration (Lundin & Schelin, 1966) . Moreover, in the thymic cortex, macromolecules incapable of freely crossing the capillary endothelium are nonetheless promptly sequestered by macrophages along the ves¬ sels (Dougherty, 1952; Raviola & Karnovsky, 1972) . In addition, fat cells may also represent an important steroid reservoir (Deslypere, Verdonck & Vermeulen, 1985) . Moreover, a similar effect of unlabelled steroids on the tissue accumulation of radioactive tracers above plasma levels has previously been observed in mouse brain and human uterus (Coutard, Osborne-Pellegrin & Funder, 1978; Laufer, Gambone, Chaudhuri et al. 1983 ).
In the spleen, cortisol also produced a retention of radioactivity above the plasma level, but this effect was only transient. There may be a possible relation¬ ship between the different capacities of the thymus and spleen to concentrate glucosteroids administered at high doses and their differential sensitivities to steroid-induced atrophy.
In the kidneys the action of cortisol on tissue accumulation of radioactivity appears complex. Dur¬ ing the first 45 min after cortisol injection the total tissue radioactivity was lower than that measured after injection of the tracer alone, suggesting that the unlabelled steroid effectively displaced the tracer from either its specific or adsorption binding sites, while during the rest of the experiment the tissue radio¬ activity of the kidneys remained higher than that observed in animals injected with tracer alone. This phenomenon appears to be due primarily to impaired steroid elimination rather than to tissue accumu¬ lation, since the organ/plasma ratio determined for the kidneys remained below one. This decreased elim¬ ination, which was also observed when considering the effect of 10 mg cortisol on the plasma radioactivity level (Fig. 2) , may be related to an effect of high doses of steroid on the vascular permeability and blood flow within the kidney, as demonstrated by the sustained increase of the renal extracellular space.
Although the various mechanisms responsible for the alterations of steroid distribution and bioavail¬ ability after administration of high doses of gluco¬ steroids are not fully understood, it appears that such treatment may induce the accumulation of the drug above plasma levels in some organs, particularly in lymphoid tissue, and that a similar phenomenon may be of importance in understanding the mechanism of 'bolus' corticotherapy.
